Affordable Access

deepdyve-link
Publisher Website

The role of nanotechnology in control of human diseases: perspectives in ocular surface diseases.

Authors
  • Rai, Mahendra1
  • Ingle, Avinash P1
  • Gaikwad, Swapnil1
  • Padovani, Felipe Hering2
  • Alves, Monica3
  • 1 a Nanobiotechnology Laboratory, Department of Biotechnology , Sant Gadge Baba Amravati University , Amravati , Maharashtra , India . , (India)
  • 2 b Institute of Medicine, Pontific Catholic University of Campinas (PUCC) , Campinas , Brazil , and. , (Brazil)
  • 3 c Department of Ophthalmology , State University of Campinas (UNICAMP) , Campinas , Brazil. , (Brazil)
Type
Published Article
Journal
Critical reviews in biotechnology
Publication Date
Oct 01, 2016
Volume
36
Issue
5
Pages
777–787
Identifiers
DOI: 10.3109/07388551.2015.1036002
PMID: 26189355
Source
Medline
Keywords
License
Unknown

Abstract

Nanotechnology is the creation and use of materials and devices on the same scale as molecules and intracellular structures, typically less than 100 nm in size. It is an emerging science and has made its way into pharmaceuticals to significantly improve the delivery and efficacy of drugs in a number of therapeutic areas, due to development of various nanoparticle-based products. In recent years, there has been increasing evidence that nanotechnology can help to overcome many of the ocular diseases and hence researchers are keenly interested in this science. Nanomedicines offer promise as viable alternatives to conventional drops, gels or ointments to improve drug delivery to the eye. Because of their small size, they are well tolerated, thus preventing washout, increase bioavailability and also help in specific drug delivery. This review describes the application of nanotechnology in the control of human diseases with special emphasis on various eye and ocular surfaces diseases.

Report this publication

Statistics

Seen <100 times